Irreversible blindness secondary to posterior reversible encephalopathy syndrome following CHOP combination chemotherapy
Hypertrophic pulmonary osteoarthropathy in mediastinal Hodgkin lymphoma in childhood
Current therapeutic approaches for patients with myelodysplastic syndromes
microRNA expression in erythropoiesis and erythroid disorders
The fundamental contribution of William Bate Hardy to shape the concept of mast cell heterogeneity
All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma
Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction
Association of G6PD202A,376G with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia
Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas
Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms
Ultra low dose thalidomide in myeloma revisited
Bortezomib for the treatment of refractory Type-1 cryoglobulinaemia
MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53wild-type CLL with a poor cytotoxic response to Nutlin-3
Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance
Decreased expression of PRDM2 (RIZ1) and its correlation with risk stratification in patients with myelodysplastic syndrome
Hepatocellular carcinoma in patients with thalassaemia syndromes
Is liver stiffness really unrelated to liver iron concentration?